PTPN13 rs989902 and CHEK2 rs738722 are associated with esophageal cancer

Ann Med. 2023;55(2):2281659. doi: 10.1080/07853890.2023.2281659. Epub 2023 Dec 1.

Abstract

Purpose: Individual genetic background can play an essential role in determining the development of esophageal squamous cell carcinoma (ESCC). PTPN13 and CHEK2 play important roles in the pathogenesis of ESCC. This case-control study aimed to analyze the association between gene polymorphisms and ESCC susceptibility.

Methods: DNA was extracted from the peripheral blood of patients. The Agena MassARRAY platform was used for the genotyping. Statistical analysis was conducted using the chi-squared test or Fisher's exact test, logistic regression analysis, and stratification analysis.

Results: The 'G' allele of rs989902 (PTPN13) and the 'T' allele of rs738722 (CHEK2) were both associated with an increased risk of ESCC (rs989902: OR = 1.23, 95% CI = 1.02-1.47, p = 0.028; rs738722: OR = 1.28, 95% CI = 1.06-1.55, p = 0.011). Stratification analysis showed that SNPs (rs989902 and rs738722) were notably correlated with an increased risk of ESCC after stratification for age, sex, smoking, and drinking status. In addition, rs738722 might be associated with lower stage, while rs989902 had a lower risk of metastasis.

Conclusion: Our findings display that PTPN13 rs989902 and CHEK2 rs738722 are associated with an increased risk of ESCC in the Chinese Han population.

Keywords: CHEK2; Esophageal squamous cell carcinoma (ESCC); PTPN13; gene; polymorphisms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Squamous Cell* / genetics
  • Case-Control Studies
  • Checkpoint Kinase 2 / genetics
  • China / epidemiology
  • Esophageal Neoplasms* / genetics
  • Esophageal Squamous Cell Carcinoma* / genetics
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Polymorphism, Single Nucleotide
  • Protein Tyrosine Phosphatase, Non-Receptor Type 13 / genetics

Substances

  • CHEK2 protein, human
  • Checkpoint Kinase 2
  • PTPN13 protein, human
  • Protein Tyrosine Phosphatase, Non-Receptor Type 13

Grants and funding

This work was supported by the 2020 Hainan Provincial Major Science and Technology Project (grant number: ZDKJ202005) and the specific research fund of The Innovation Platform for Academicians of Hainan Province (grant number: YSPTZX202029).